Literature DB >> 1621726

Drug-related emergency department visits and hospital admissions.

B S Prince1, C M Goetz, T L Rihn, M Olsky.   

Abstract

The incidence and causes of drug-related hospital admissions and visits to an emergency department were evaluated. A retrospective chart review was conducted to identify drug-related visits and admissions for all patients who visited the emergency department of a 517-bed tertiary-care institution during a four-month period. Drug-related illnesses were classified as adverse drug reaction (ADR), overdose or abuse, noncompliance, drug interaction, or toxicity. Patient data included demographic characteristics, medication history, serum drug concentrations, length of hospital stay, and hospital admission charges. Of 10,184 patients who visited the emergency department, 293 (2.9%) had drug-related illnesses; 71 (24%) of these patients were admitted. The drug classes most commonly involved were drugs of abuse (23.2%), anticonvulsants (17.1%), antibiotics (12.6%), respiratory drugs (8.9%), and pain medications (8.9%). The most common category of drug-related illness was overdose or abuse (35%) followed by noncompliance (28%), ADR (28%), toxicity (8%), and drug interaction (1%). The average length of stay for patients who were admitted was 5.8 days, and the average cost of admission was $8888. Drug-related illnesses accounted for 2.9% of hospital admissions and visits for patients in the emergency department. The most commonly identified drug-related illnesses were overdose or abuse, noncompliance, and ADRs; the drug classes most commonly implicated were drugs of abuse, anticonvulsants, and antibiotics.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1621726

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  30 in total

1.  Clinical pharmacy interventions by community pharmacists during the dispensing process.

Authors:  G M Hawksworth; A J Corlett; D J Wright; H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

2.  Teaching medication adherence in US colleges and schools of pharmacy.

Authors:  Nathaniel M Rickles; Linda Garrelts MacLean; Karl Hess; Kevin C Farmer; Afton M Yurkon; Carolyn C Ha; Emmanuelle Schwartzman; Anandi V Law; Paul A Milani; Katie Trotta; Sara R Labella; Rebecca J Designor
Journal:  Am J Pharm Educ       Date:  2012-06-18       Impact factor: 2.047

3.  Practitioners' views on computerized drug-drug interaction alerts in the VA system.

Authors:  Yu Ko; Jacob Abarca; Daniel C Malone; Donna C Dare; Doug Geraets; Antoun Houranieh; William N Jones; W Paul Nichol; Gregory P Schepers; Michelle Wilhardt
Journal:  J Am Med Inform Assoc       Date:  2006-10-26       Impact factor: 4.497

4.  Validation of a comprehensive classification tool for treatment-related problems.

Authors:  Salah M AbuRuz; Nailya R Bulatova; Almoatasem M Yousef
Journal:  Pharm World Sci       Date:  2006-10-26

Review 5.  Methods for causality assessment of adverse drug reactions: a systematic review.

Authors:  Taofikat B Agbabiaka; Jelena Savović; Edzard Ernst
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Drug-related visits to the emergency department in a Spanish university hospital.

Authors:  Isabel Castro; José Ma Guardiola; Laura Tuneu; Ma Luisa Sala; Ma José Faus; Ma Antonia Mangues
Journal:  Int J Clin Pharm       Date:  2013-05-22

Review 7.  Clinical pharmacy in primary care.

Authors:  G M Hawksworth; H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

8.  Regional surveillance of emergency-department visits for outpatient adverse drug events.

Authors:  A Capuano; A Irpino; M Gallo; L Ferrante; M L Illiano; B Rinaldi; A Filippelli; F Rossi
Journal:  Eur J Clin Pharmacol       Date:  2009-03-18       Impact factor: 2.953

9.  Frequency and preventability of adverse drug reactions in paediatric patients.

Authors:  Mary E Temple; Renee F Robinson; Julie C Miller; John R Hayes; Milap C Nahata
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

10.  Be careful, mom and doc: hepatotoxicity associated with prescribed medications in young infants.

Authors:  Kam-Lun Ellis Hon; Alexander K C Leung
Journal:  Int J Pediatr       Date:  2009-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.